Nabla

Nabla sells recurring per-clinician subscriptions to healthcare organizations: health systems, academic medical centers, safety-net hospitals, and physician groups sign annual contracts scaled to the number of clinicians using the ambient assistant, which listens to patient encounters and drafts structured clinical notes. The buyer is institutional — health-system and medical-group leadership — though the product wins bottom-up because documentation relief is felt by clinicians daily. With deployments across more than 130 US healthcare organizations, the motion is land-and-expand: start with a department or specialty, then spread across the system as adoption proves out. The 2025 Series C strategy extends the same contracts upward: agentic clinical workflows — automating orders, coding, and downstream documentation tasks — raise the value and defensible price per clinician seat, moving Nabla from a documentation line item toward workflow infrastructure. Revenue is recurring, churn risk concentrates at system-wide renewals, and the structural pricing pressure comes from EHR vendors bundling competing ambient features into software hospitals already own.